Skip to content
Search

Latest Stories

NHS Long Term Workforce Plan: 350 more medical school places allocated

NHS Long Term Workforce Plan:  350 more medical school places allocated

The Office for Students (OfS) has targeted under-doctored areas in its allocation of the medical school places

The government has allocated an additional 350 medical school places in England, making a significant step in delivering the NHS Long Term Workforce Plan.


Supported by more than £2.4 billion in government funding, the plan outlines the strategy for recruiting and retaining hundreds of thousands more staff over the next 15 years to deliver the future workforce the NHS requires.

One of the key commitments of the NHS Long Term Workforce Plan is to double the number of medical school places in England to 15,000 by 2031.

As part of the ongoing efforts to fulfill this pledge, the Office for Students (OfS) has designated 350 places for medical schools nationwide for the academic year 2025 to 2026, targeting under-doctored areas.

This will lead to a significant rise in the number of medical schools at universities in Sunderland, Leeds, East Anglia, Anglia Ruskin, Plymouth, and Surrey. Notably, the University of Surrey is receiving government-funded places for the first time.

Health and Social Care Secretary Victoria Atkins praised the government's workforce plan, highlighting, "The NHS now has record funding and a record number of doctors."

“I want to make sure that we will have the medical professionals we will need in the years ahead.

“That’s why we are delivering the NHS Long Term Workforce Plan and doubling the number of medical school places, so we can train the next generation of world-class doctors to offer patients the highest-quality care,” she added.

Education Secretary Gillian Keegan said that the expansion of medical school places, combined with the introduction  of new doctor degree apprenticeship, has created unprecedented career opportunities in medicine.

Amanda Pritchard, CEO of NHS England, commented: “This is a hugely important moment for the NHS Long Term Workforce Plan and marks one of the first steps towards our ambition to train more doctors in England than ever before - the record expansion will help us boost care for patients right across the country.”

“The ambitious blueprint for our workforce is a once-in-a-generation opportunity to put NHS staffing on a sustainable footing, particularly as we continue to adapt to new and rising demand for health services.”

Last year,  the government allocated 205 additional medical school places for the 2024 to 2025 academic year, including providing government-funded places to three schools for the first time.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less